Post Tagged with: "pharmaceutical"

16th EU-Canada Summit, 30 October 2016 by European External Action Service (CC BY-NC 2.0)

CETA Bill Hits 2nd Reading as Officials Admit They Haven’t Studied Financial Impact of Patent Reforms

The costs associated with the increased patent protections for pharmaceutical drugs in the trade agreement between Canada and the European Union has long been one of the most controversial elements of the deal. At least one study has pegged the cost to provincial health care at more than a billion dollars. In response to those concerns, the Conservative government promised to compensate the provinces for the increased costs. Earlier this year, when officials from Health Canada appeared before a House of Commons committee, they acknowledged that it is hard to estimate the actual cost but that they knew that the agreement would increase the costs of drugs in Canada.

Last week, Steve Verheul, the lead Canadian CETA negotiator, appeared before another House of Commons committee and was asked if the department has done any analysis on the financial impact of the extended patent protection. Remarkably, Verheul said that it has not, arguing that it is difficult to come up with a projection. In fact, when pressed on the issue, Verheul speculated that perhaps costs would not increase since Canadians already pays higher prices for pharmaceutical drugs than consumers in European countries such as the UK, France or Germany.

These comments from Canada’s lead CETA negotiations are simply bewildering.

Read more ›

November 21, 2016 5 comments News

Canada Reportedly Ready to Cave on CETA Drug Patent Demands

The Canadian Press reports that Canada is ready to cave to European demands for changes to patent rules that could cost Canadians hundreds of millions of dollars in higher health care costs. The ministerial meeting on the remaining CETA issues is set for next week.

Read more ›

November 14, 2012 1 comment News

Why Ed Fast Holds One of The Keys To Health Care Costs

Appeared in the Toronto Star on June 5, 2011 as EU/Big Pharma Deal Would Raise Health Care Costs Ed Fast, Canada’s new Minister of International Trade, may not be household name, yet the B.C. Minister is set to play a key role in one of Canada’s top domestic priorities – […]

Read more ›

June 9, 2011 Comments are Disabled Columns Archive

Supreme Court Rules Against Patent Evergreening

The Canadian Supreme Court has issued another decision that recognized the limits of intellectual property.  This case, a pharmaceutical patent fight between AstraZeneca and Apotex, includes language from the court that explicitly warns against the practice of evergreening, whereby pharmaceutical companies seek to extend the life of patent protection by […]

Read more ›

November 3, 2006 1 comment News